Evidence map›Paper›PMID 41835720›Full record

ReviewCureus2026

Hyperprolactinemia in Older Adults: A Narrative Review of Distinct Clinical Challenges and Management Strategies.

Andres F Quimbayo-Cifuentes

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Andres F Quimbayo-CifuentesInternal Medicine and Geriatrics, Centros Medicos Colsanitas SAS, Armenia, COL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperprolactinemia in older adults represents a significant diagnostic and therapeutic challenge, as its manifestations can often be masked by symptoms typically associated with normal aging. Unlike in younger populations, the primary cause of this condition in the elderly is the use of medications, such as antipsychotics, antiemetics, and prokinetics. The clinical presentation of excessive prolactin production in the elderly varies significantly, and the diagnostic approach requires a high index of clinical suspicion and a thorough review of potentially involved medications. Management must be individualized, carefully selecting candidates for dopamine agonist therapy or, in cases of pituitary adenomas, surgical or radiotherapeutic management. This review synthesizes the evidence on these atypical presentations and the nuances of management tailored to the older adult.

Indexed as

agedcomorbiditydiagnosishyperprolactinemiapituitary diseasesprolactintherapeutics

Identifiers

PMID41835720
PMCPMC12988703

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.